Skip to content
Home/Companies/Healthcare/Venatorx Pharmaceuticals
Venatorx Pharmaceuticals

Venatorx Pharmaceuticals

Healthcare·US·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Venatorx Pharmaceuticals?

Venatorx Pharmaceuticals is currently owned by Abingworth through Abingworth Bioventures VI (2014 vintage), since 2022.

Hand-verified · updated 2026-06-10

Abingworth
Investor
Abingworth
Abingworth Bioventures VI · 2014 · Life Sciences VC

Key facts

HQUS
SectorHealthcare
StatusActive
Websitevenatorx.com

More from Abingworth Bioventures VI

Other portfolio companies in the same fund.

Verona Pharma
Verona Pharma
Exited 2025
BiotechUK
to
Exicure
Active
BiotechUS· 2019
Soleno Therapeutics
Soleno Therapeutics
Exited 2026
BiotechUS· 2018
to
Tizona Therapeutics
Tizona Therapeutics
Active
BiotechUS· 2016
Median Technologies
Active
HealthcareFrance· 2015
Avedro
Exited 2019
MedTechUS· 2014
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track Venatorx Pharmaceuticals

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Venatorx Pharmaceuticals.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue